Frontiers Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
Por um escritor misterioso
Descrição
Frontiers in Pharmacology Pharmacogenetics and Pharmacogenomics
Pediatric acute lymphoblastic leukemia
Frontiers Association of the clinical profile and overall survival of pediatric patients with acute lymphoblastic leukemia
Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
Variants in vincristine pharmacodynamic genes involved in neurotoxic
Frontiers Molecular Approaches to Treating Pediatric Leukemias
Frontiers Insights on epithelial cells at the single-cell level in hepatocellular carcinoma prognosis and response to chemotherapy
Frontiers Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology
The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment - ScienceDirect
Frontiers Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology
45623 PDFs Review articles in PHARMACOGENETICS
Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico
The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades, Journal of Hematology & Oncology
Frontiers in Pharmacology Pharmacogenetics and Pharmacogenomics
de
por adulto (o preço varia de acordo com o tamanho do grupo)
